Literature DB >> 7486907

Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells.

W A Belli1, J Fryklund.   

Abstract

ATPase activity in permeabilized cells of Helicobacter pylori as well as those of Helicobacter felis and Campylobacter jejuni was analyzed. The ATPase activities in these cells were most susceptible to sodium azide, fluoroaluminate, and dicyclohexylcarbodiimide, which are typical inhibitors of F ATPases. Optimal values for maximal activity were found to be at approximately pH 6.4, 6.0, and 6.0 for C. jejuni, H. pylori, and H. felis, respectively. The substituted benzimidazole compounds omeprazole, lansoprazole, and Eisai 3810 were found to have no effect on the F ATPase activity of H. pylori at concentrations which are inhibitory for cell growth (MICs). In addition, an extracellular, vanadate-susceptible ATPase activity was detected in H. pylori, which was also relatively insusceptible to the benzimidazole compounds. Thus, the mechanism of killing mediated by omeprazole and related compounds in Helicobacter pylori does not appear to be due to diminished ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486907      PMCID: PMC162814          DOI: 10.1128/AAC.39.8.1717

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  A convenient method for the ATPase assay.

Authors:  D LeBel; G G Poirier; A R Beaudoin
Journal:  Anal Biochem       Date:  1978-03       Impact factor: 3.365

2.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Helicobacter pylori comb. nov. Exhibits Facultative Acidophilism and Obligate Microaerophilism.

Authors:  N Kangatharalingam; P S Amy
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

4.  Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.

Authors:  K A Eaton; C L Brooks; D R Morgan; S Krakowka
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 5.  Microbiological aspects of Helicobacter pylori (Campylobacter pylori).

Authors:  C S Goodwin; J A Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

6.  Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors.

Authors:  F Mauch; G Bode; P Malfertheiner
Journal:  Am J Gastroenterol       Date:  1993-10       Impact factor: 10.864

Review 7.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

8.  Periplasmic phosphatases in Salmonella typhimurium LT2. A biochemical, physiological, and partial genetic analysis of three nucleoside monophosphate dephosphorylating enzymes.

Authors:  W Uerkvitz; C F Beck
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

9.  Growth of Campylobacter pylori in liquid media.

Authors:  D R Morgan; R Freedman; C E Depew; W G Kraft
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid.

Authors:  B J Marshall; L J Barrett; C Prakash; R W McCallum; R L Guerrant
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

View more
  6 in total

1.  Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp.

Authors:  J E Sjøstrøm; T Kühler; H Larsson
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution.

Authors:  Y Barak; D F Ackerley; C J Dodge; L Banwari; C Alex; A J Francis; A Matin
Journal:  Appl Environ Microbiol       Date:  2006-11       Impact factor: 4.792

3.  Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.

Authors:  K Nagata; N Sone; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Analysis of F1F0-ATPase from Helicobacter pylori.

Authors:  C C McGowan; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions.

Authors:  J E Sjöström; J Fryklund; T Kühler; H Larsson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus.

Authors:  Róbert Sutak; Jan Tachezy; Jaroslav Kulda; Ivan Hrdý
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.